Skip to main content
. 2009 Jun;296(6):E1311–E1318. doi: 10.1152/ajpendo.90972.2008

Table 1.

Food intake, body weight, and abdominal trunk composition in dogs maintained on a HHFD

Variable Week 0 Week 2 Week 6 Week 12 Week 16
Rimonabant group (n = 11)
FI, kcal·kg−1·day−1 80.2±3.7 65.1±4.1a,d 80.6±5.0 73.7±3.2 70.0±3.1
Body wt, kg 31.7±1.3 29.9±1.1c 30.1±1.1c 30.6±1.2a 30.8±1.1b
Abdominal trunk
    TT, cm3 3,105.6±145.5 2,953.7±115.9 2,898.9±125.5b 3,056.3±123.4 3,062.6±134.4
    NFT, cm3 2,016.0±88.0 2,004.2±75.3e 2,010.0±71.1 2,103.0±82.1 2,126.9±85.5
    TF, cm3 1,089.5±118.3 949.5±95.2b 888.9±109.3c 953.3±93.1b 935.6±108.2b
    VAT, cm3 611.3±57.9 523.6±41.6 519.7±60.0 574.0±48.7 555.9±63.9
    SAT, cm3 478.3±63.5 425.8±59.1 369.2±54.7c 379.3±46.9c 379.7±48.9c
    VAT/SAT 1.4±0.1 1.2±0.1 1.5±0.1 1.6±0.1b 1.5±0.1
    TF (%) of the TT 34.5±2.4 31.7±2.3 29.9±2.7c 30.8±2.2a 29.9±2.6c
    VAT (%) of the TF 57.1±1.4 56.3±1.9 59.2±1.9 61.0±1.3b 59.7±1.4
    SAT (%) of the TF 42.9±1.4 43.7±1.9 40.8±1.9 39.0±1.3b 40.3±1.4
Placebo group (n = 9)
FI, kcal·kg−1·day−1 84.8±4.1 81.2±3.0 83.4±3.6 80.2±5.7 76.3±4.3
Body wt, kg 31.8±1.5 31.8±1.5 32.4±1.5 33.5±1.7c 33.9±1.9c
Abdominal trunk:
    TT, cm3 3,113.7±143.4 3,173.4±146.0 3,220.9±161.6 3,371.8±218.7b 3,404.5±207.4b
    NFT, cm3 2,233.1±106.8 2,229.2±63.9 2,241.1±91.7 2,283.7±113.2 2282.7±99.2
    TF, cm3 880.6±138.2 944.1±138.6 979.8±165.9 1,088.1±202.9a 1,121.8±194.7c
    VAT, cm3 506.0±70.3 551.2±76.6 555.9±83.9 624.9±112.4b 641.0±103.8a
    SAT, cm3 374.6±74.8 393.0±70.5 423.9±88.3 463.2±95.9a 480.8±97.5c
    VAT/SAT 1.5±0.2 1.3±0.2 1.4±0.2 1.4±0.1 1.4±0.1
    TF (%) of the TT 27.7±3.2 28.9±2.8 29.5±3.3 30.9±3.6a 31.7±3.4c
    VAT (%) of the TF 58.6±2.8 58.9±2.8 57.8±2.6 57.8±2.3 57.8±2.6
    SAT (%) of the TF 41.4±2.8 41.1±2.8 42.2±2.6 42.2±2.3 42.2±2.6

Values are means ± SE. FI, food intake; HHFD, hypercaloric high-fat diet; NFT, nonfat tissue; SAT, subcutaneous adipose tissue; TF, total fat; TT, total tissue; VAT, visceral adipose tissue.

a

P < 0.01,

b

P < 0.05, and

c

P < 0.001 compared with week 0.

d

P < 0.01 and

e

P < 0.05 compared with placebo.